Evidence map›Paper›PMID 30625002›Full record

ArticleJournal of neurophysiology2019

β

Timothy W Church, Jon T Brown, Neil V Marrion

Open access · bronzeAbstract read
In one paragraph

Article in Journal of neurophysiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Timothy W ChurchSchool of Physiology, Pharmacology and Neuroscience, University of Bristol , Bristol , United Kingdom.
Jon T BrownUniversity of Exeter Medical School , Exeter , United Kingdom.
Neil V MarrionSchool of Physiology, Pharmacology and Neuroscience, University of Bristol , Bristol , United Kingdom.
University of Bristol · GBUniversity of Exeter · GB

Funding

Medical Research Council
6 · The paper itself

Abstract

Action potential firing in hippocampal pyramidal neurons is regulated by generation of an afterhyperpolarization (AHP). Three phases of AHP are recognized, with the fast AHP regulating action potential firing at the onset of a burst and the medium and slow AHPs supressing action potential firing over hundreds of milliseconds and seconds, respectively. Activation of β-adrenergic receptors suppresses the slow AHP by a protein kinase A-dependent pathway. However, little is known regarding modulation of the medium AHP. Application of the selective β-adrenergic receptor agonist isoproterenol suppressed both the medium and slow AHPs evoked in rat CA1 hippocampal pyramidal neurons recorded from slices maintained in organotypic culture. Suppression of the slow AHP was mimicked by intracellular application of cAMP, with the suppression of the medium AHP by isoproterenol still being evident in cAMP-dialyzed cells. Suppression of both the medium and slow AHPs was antagonized by the β-adrenergic receptor antagonist propranolol. The effect of isoproterenol to suppress the medium AHP was mimicked by two β

Indexed as

Membrane PotentialsAdrenergic beta-AgonistsAnimalsCA1 Region, HippocampalCyclic AMPEthanolaminesIsoproterenolMalePotassium Channel BlockersPyramidal CellsPyrimidinesRatsRats, WistarReceptors, Adrenergic, betaSmall-Conductance Calcium-Activated Potassium ChannelsTetrahydronaphthalenesAdrenergic beta-AgonistsamibegronBRL 37344Cyclic AMPEthanolaminesICI D2788IsoproterenolPotassium Channel BlockersPyrimidinesReceptors, Adrenergic, betaSmall-Conductance Calcium-Activated Potassium ChannelsTetrahydronaphthalenesafterhyperpolarizationhippocampusmodulation

Identifiers

PMID30625002
PMCPMC6520626
OpenAlexW2909013294

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.